ZURA Earnings Date: Mar 31, 2027 (Estimated) — Zura Bio Limited
NASDAQ · Healthcare · Biotechnology
Updated
When is ZURA's next earnings date?
Zura Bio Limited (ZURA) is expected to report Q4 2027 earnings on Wednesday, March 31, 2027 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20.
How did ZURA do in its last earnings report?
In its most recent report on Oct 27, 2026, Zura Bio Limited posted EPS of -$0.20 versus the -$0.20 estimate, a beat of 1.9%. The stock's 1-day post-earnings move was +22.2%.
How much does ZURA stock move after earnings?
ZURA beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.9% (up or down) in the day after earnings.
About Zura Bio Limited
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
🤖 AI Earnings Analysis
Zura Bio’s third-quarter update offers no disclosed catalyst details, leaving the clinical-stage biotech’s outlook difficult to assess. The $0.20 loss beat estimates by $0.02, but remains a weak standalone signal without revenue or pipeline milestones.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | -0.20 | -0.20 | +1.93% | — | ✅ Beat | +22.19% | — | — | |
| 2026-08-11 | Q2 2026 | -0.19 | -0.21 | -10.53% | $0 | ❌ Miss | -1.24% | +0.89% | +1.42% |
| 2026-05-07 | Q1 2026 | -0.18 | -0.22 | -22.22% | $0 | ❌ Miss | -7.16% | -1.84% | -30.47% |
| 2026-03-19 | Q3 2025 | -0.16 | -0.49 | -206.25% | $0 | ❌ Miss | +2.17% | -6.18% | -3.00% |
| 2026-03-19 | Q4 2026 | -0.19 | -0.49 | -157.89% | $0 | ❌ Miss | +2.17% | -6.18% | -3.00% |
| 2025-11-13 | Q4 2025 | -0.18 | -0.21 | -16.67% | $0 | ❌ Miss | -9.72% | -16.41% | -13.17% |
| 2025-08-14 | Q2 2025 | -0.19 | -0.17 | +10.53% | $0 | ✅ Beat | +8.18% | +10.06% | +25.79% |
| 2025-03-25 | Q3 2024 | -0.12 | -0.08 | +33.33% | $0 | ✅ Beat | +10.37% | -4.44% | +6.67% |
Showing last 8 quarters.